Using isogenic clinical bloodstream Staphylococcus aureus strains from a patient with relapsing endocarditis, we in-vestigated the transcriptional profiles of the mprF and dlt genes in the context of cell-surface charge and daptomycin nonsusceptibility. As in prior studies, a point mutation within mprF was observed in the daptomycin-nonsusceptible strain. However, neither the transcriptional profile of mprF nor the membrane phospholipid analyses were compatible with the anticipated mprF gain-in-function phenotype. In contrast, we demonstrated enhanced dlt expression coinci-dent with increased positive surface charge and reduced dap-tomycin binding. With the increasing use of daptomycin in clinical practice, there have been a number of recen...
Over the past several years, single-nucleotide polymorphisms (SNPs) within themprF open reading fram...
Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to characterize ...
Background: Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to c...
We used a well-characterized isogenic set of clinical bloodstream Staphylococcus aureus strains to s...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
Daptomycin (DAP) is one of the most potent antibiotics used for the treatment of methicillin-resista...
The extensive use of daptomycin (DAP) for treatment of methicillin-resistant Staphylococcus aureus (...
<div><p>Development of <i>in vivo</i> daptomycin resistance (DAP-R) among <i>Staphylococcus aureus</...
Over the past several years, single-nucleotide polymorphisms (SNPs) within the mprF open reading fra...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...
Over the past several years, single-nucleotide polymorphisms (SNPs) within themprF open reading fram...
Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to characterize ...
Background: Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to c...
We used a well-characterized isogenic set of clinical bloodstream Staphylococcus aureus strains to s...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Development of in vivo daptomycin resistance (DAP-R) among Staphylococcus aureus clinical isolates, ...
Objectives: Daptomycin (DAP) resistance in Staphylococcus aureus is uncommon but there are increasin...
Daptomycin (DAP) is one of the most potent antibiotics used for the treatment of methicillin-resista...
The extensive use of daptomycin (DAP) for treatment of methicillin-resistant Staphylococcus aureus (...
<div><p>Development of <i>in vivo</i> daptomycin resistance (DAP-R) among <i>Staphylococcus aureus</...
Over the past several years, single-nucleotide polymorphisms (SNPs) within the mprF open reading fra...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...
The mechanisms leading to reduced susceptibility to daptomycin (DAP) are multifactorial and have not...
Over the past several years, single-nucleotide polymorphisms (SNPs) within themprF open reading fram...
Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to characterize ...
Background: Daptomycin remains one of our last-line anti-staphylococcal agents. This study aims to c...